3,300 Shares in Colgate-Palmolive Company $CL Bought by Mraz Amerine & Associates Inc.

Key Points

• Mraz Amerine & Associates Inc. purchased 3,300 shares of Colgate-Palmolive Company, valued at around $300,000, in the second quarter.
• The company reported $0.92 EPS for its last quarter, beating expectations, with revenue up 1.0% year-over-year.
• Colgate-Palmolive declared a quarterly dividend of $0.52 per share, with an annualized dividend yield of 2.7%.

Mraz Amerine & Associates Inc. bought a new stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,300 shares of the company's stock, valued at approximately $300,000.

Several other large investors also recently made changes to their positions in CL. Brighton Jones LLC lifted its holdings in Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock worth $962,000 after purchasing an additional 450 shares during the last quarter. Gateway Investment Advisers LLC lifted its stake in shares of Colgate-Palmolive by 18.7% in the first quarter. Gateway Investment Advisers LLC now owns 14,085 shares of the company's stock worth $1,320,000 after buying an additional 2,221 shares during the last quarter. Miracle Mile Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 3.5% during the 1st quarter. Miracle Mile Advisors LLC now owns 12,651 shares of the company's stock worth $1,185,000 after buying an additional 429 shares during the period. OLD National Bancorp IN grew its stake in Colgate-Palmolive by 2.2% in the 1st quarter. OLD National Bancorp IN now owns 7,859 shares of the company's stock valued at $736,000 after buying an additional 171 shares during the last quarter. Finally, Park Avenue Securities LLC raised its holdings in Colgate-Palmolive by 15.7% in the 1st quarter. Park Avenue Securities LLC now owns 9,989 shares of the company's stock worth $936,000 after acquiring an additional 1,356 shares during the period. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $77.39 on Tuesday. The firm has a market capitalization of $62.55 billion, a price-to-earnings ratio of 21.74, a PEG ratio of 4.06 and a beta of 0.34. Colgate-Palmolive Company has a one year low of $77.32 and a one year high of $102.61. The business has a fifty day simple moving average of $83.11 and a 200 day simple moving average of $88.21. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. During the same quarter in the previous year, the firm posted $0.91 EPS. The business's revenue for the quarter was up 1.0% on a year-over-year basis. Sell-side analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be given a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive's dividend payout ratio is 58.43%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on CL shares. Barclays decreased their price target on shares of Colgate-Palmolive from $87.00 to $82.00 and set an "equal weight" rating for the company in a report on Wednesday, October 1st. Citigroup decreased their target price on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating for the company in a research note on Monday, August 4th. The Goldman Sachs Group dropped their price target on Colgate-Palmolive from $106.00 to $91.00 and set a "buy" rating on the stock in a research report on Thursday, October 2nd. Weiss Ratings reissued a "hold (c)" rating on shares of Colgate-Palmolive in a research report on Saturday, September 27th. Finally, Morgan Stanley dropped their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Seven research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, Colgate-Palmolive presently has an average rating of "Hold" and a consensus price target of $94.83.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.